Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Assessing newborn scalp hair can reveal important health information.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Low iron levels are linked to hair loss in women.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Monilethrix causes short, fragile hair with no specific treatment available.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Hair changes can indicate systemic diseases or medication effects.

A gluten-free diet stopped a child's hair-eating behavior and suggested she had celiac disease.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

One-third of patients on home nutrition had micronutrient deficiencies, with iron deficiency being most common, but serious issues were rare.

Two Australian Poll Hereford calves had severe anaemia, abnormal red blood cells, and skin issues.

The study found that tight junctions reach the top layer of the skin's stratum granulosum, not just the second top layer as previously thought.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Anticonvulsant drugs may cause temporary chromosomal abnormalities.